NIH clinical trial of investigational vaccine for COVID-19 begins

Study enrolling Seattle-based healthy adult volunteers.

COVID-19 vaccine development and a potential nanomaterial path forward

First Clinical Trial of COVID-19 Investigational Vaccine Begins in Seattle

Vaccines, Free Full-Text

National Institutes of Health (NIH) - Launched in record speed, #NIH started enrollment for a Phase 1 #clinicaltrial of an investigational vaccine for # COVID19 for healthy adults in the Seattle area. .gov/news-events/news-releases/nih

NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

Phase III trial of Pfizer-BioNTech Covid-19 vaccine starts in South Africa

Management of COVID-19: current status and future prospects - ScienceDirect

A review of potential treatments to date in COVID-19 patients according to the stage of the disease - ScienceDirect

An overview of key potential therapeutic strategies for combat in the COVID-19 battle - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05434H

NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins

First Phase 3 clinical trial of a coronavirus vaccine in the United States begins

SARS – NIH Director's Blog

SARS – NIH Director's Blog

NIH begins clinical trial for Epstein-Barr virus vaccine

COVID-19 vaccine appears more effective if received around midday – Washington University School of Medicine in St. Louis